Auxilium
Pharmaceuticals Inc. (Nasdaq: AUXL) received an acquisition offer from Endo
Pharmaceuticals valued at approximately $2.2 billion sending the stock price soaring $9.45 to $30.97.
Auxilium receives acquisition offer
September 17, 2014 at 13:07 PM EDT
